• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5082040)   Today's Articles (2)
For: Diriba G, Alemu A, Yenew B, Tola HH, Gamtesa DF, Mollalign H, Eshetu K, Moga S, Abdella S, Tollera G, Kebede A, Dangisso MH. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Int J Infect Dis 2023;132:50-63. [PMID: 37072053 PMCID: PMC10302157 DOI: 10.1016/j.ijid.2023.04.392] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Revised: 03/11/2023] [Accepted: 04/10/2023] [Indexed: 04/20/2023]  Open
Number Cited by Other Article(s)
1
Ansari MS, Zohib M, Kumari M, Yadav V, Pal RK, Tripathi S, Jain A, Biswal BK, Arora A. Structural and biophysical characterization of PadR family protein Rv0047c of Mycobacterium tuberculosis H37Rv. J Struct Biol 2025;217:108211. [PMID: 40403899 DOI: 10.1016/j.jsb.2025.108211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2025] [Revised: 04/22/2025] [Accepted: 05/19/2025] [Indexed: 05/24/2025]
2
Diriba G, Alemu A, Yenew B, Ayano BZ, Hailu M, Buta B, Wondimu A, Tefera Z, Meaza A, Seid G, Getahun M, Dagne B, Mollalign H, Abebaw Y, Getu M, Tadesse M, Belhu T, Alemu E, Demissie M, Erresso A, Aga G, Kumsa A, Letta T, Abdella S, Moga S, Dangisso MH, Tollera G, Tadesse G. Second-line drug resistance among multidrug-resistant tuberculosis patients in Ethiopia: A laboratory-based surveillance. J Glob Antimicrob Resist 2025;42:167-174. [PMID: 39988072 DOI: 10.1016/j.jgar.2025.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2024] [Revised: 02/03/2025] [Accepted: 02/14/2025] [Indexed: 02/25/2025]  Open
3
Aranaga C, Varela R, Falco A, Villa J, Moreno LM, Causse M, Martínez-Martínez L. In Vitro Activity of the Triazinyl Diazepine Compound FTSD2 Against Drug-Resistant Mycobacterium tuberculosis Strains. Pharmaceuticals (Basel) 2025;18:360. [PMID: 40143137 PMCID: PMC11945624 DOI: 10.3390/ph18030360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2024] [Revised: 02/27/2025] [Accepted: 02/28/2025] [Indexed: 03/28/2025]  Open
4
Maani AA, Petersen E, Memish ZA. The critical role of new tuberculosis vaccines in achieving the WHO 2035 End TB target. IJID REGIONS 2025;14:100595. [PMID: 40201559 PMCID: PMC11973680 DOI: 10.1016/j.ijregi.2025.100595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 01/12/2025] [Revised: 01/30/2025] [Accepted: 01/31/2025] [Indexed: 04/10/2025]
5
Hailu BK, Demessie Y, Gessese AT, Dagnaw GG, Dejene H. Multidrug Resistance Tuberculosis in the Context of Co-Infection in Ethiopia: A Systematic Review and Meta-Analysis. J Epidemiol Glob Health 2025;15:19. [PMID: 39909956 PMCID: PMC11799485 DOI: 10.1007/s44197-025-00360-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2024] [Accepted: 12/16/2024] [Indexed: 02/07/2025]  Open
6
Raqib R, Sarker P. Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis. Biomolecules 2024;14:1497. [PMID: 39766204 PMCID: PMC11673177 DOI: 10.3390/biom14121497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2024] [Revised: 11/15/2024] [Accepted: 11/22/2024] [Indexed: 01/11/2025]  Open
7
Moe S, Azamat I, Allamuratova S, Oluya M, Khristusev A, Rekart ML, Mamitova K, Bidwell G, Gomez-Restrepo C, Kalmuratov B, Tigay Z, Parpieva N, Safaev K, Sitali N, Gomez D, Mikhail A, Sinha A. Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan. IJTLD OPEN 2024;1:391-397. [PMID: 39301133 PMCID: PMC11409172 DOI: 10.5588/ijtldopen.24.0351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Accepted: 07/10/2024] [Indexed: 09/22/2024]
8
Joshi P, Singh KG, Patidar V, Gupta V. Evaluation of Diagnostic Methods and Rifampicin Resistance in Pulmonary Tuberculosis: A Hospital-Based Study. Cureus 2024;16:e67062. [PMID: 39286711 PMCID: PMC11403642 DOI: 10.7759/cureus.67062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/22/2024] [Indexed: 09/19/2024]  Open
9
Chen YL, Xie YQ, Wei MY, Xu DM. Clinical effects of detailed nursing management interventions on medication adherence and disease perception in patients with drug-resistant tuberculosis. World J Clin Cases 2024;12:4191-4198. [PMID: 39015906 PMCID: PMC11235556 DOI: 10.12998/wjcc.v12.i20.4191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Revised: 05/16/2024] [Accepted: 05/29/2024] [Indexed: 06/30/2024]  Open
10
Diriba G, Alemu A, Ayano BZ, Yenew B, Hailu M, Buta B, Wondimu A, Tefera Z, Ababu Z, Ebisa Y, Moga S, Tadesse G. Acquired bedaquiline and fluoroquinolones resistance during treatment follow-up in Oromia Region, North Shewa, Ethiopia. IDCases 2024;36:e01988. [PMID: 38779144 PMCID: PMC11109312 DOI: 10.1016/j.idcr.2024.e01988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Revised: 05/01/2024] [Accepted: 05/07/2024] [Indexed: 05/25/2024]  Open
11
Fu L, Wang W, Xiong J, Zhang P, Li H, Zhang X, Liang H, Yang Q, Wang Z, Chen X, Deng G, Cai Y, Tang S. Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication. Infect Drug Resist 2024;17:595-604. [PMID: 38390619 PMCID: PMC10882277 DOI: 10.2147/idr.s443897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Accepted: 02/12/2024] [Indexed: 02/24/2024]  Open
12
Fu L, Xiong J, Wang H, Zhang P, Yang Q, Cai Y, Wang W, Sun F, Zhang X, Wang Z, Chen X, Zhang W, Deng G. Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]. BMC Infect Dis 2023;23:834. [PMID: 38012543 PMCID: PMC10683225 DOI: 10.1186/s12879-023-08644-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Accepted: 09/25/2023] [Indexed: 11/29/2023]  Open
13
Joshi T, Nain P, Bhamra P, Kaur J. Favorable clinical outcomes and anti-mycobacterial efficacy of pretomanid in patients with highly resistant tuberculosis: A review. Indian J Tuberc 2023;71 Suppl 1:S130-S135. [PMID: 39067944 DOI: 10.1016/j.ijtb.2023.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2022] [Revised: 09/16/2023] [Accepted: 09/22/2023] [Indexed: 07/30/2024]
14
Fu L, Zhang X, Xiong J, Sun F, Weng T, Li Y, Zhang P, Li H, Yang Q, Cai Y, Liang H, Chen Q, Wang Z, Liu L, Chen X, Zhang W, Deng G. Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study. Int J Infect Dis 2023;135:101-108. [PMID: 37567554 DOI: 10.1016/j.ijid.2023.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Revised: 08/02/2023] [Accepted: 08/04/2023] [Indexed: 08/13/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Excel